SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,537.72 628.04
( 0.82%)

Global Indices

Nasdaq

52,797.06 -686.99
(-1.28%)

Dow Jones

7,662.83 -66.15
(-0.86%)

Hang Seng

66,220.29 893.87
(1.37%)

Nikkei 225

10,756.24 12.89
(0.12%)

Forex

USD-INR

95.70 0.10
(0.10%)

EUR-INR

110.78 0.02
(0.01%)

GBP-INR

129.52 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Emcure Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544210

INE168P01015

195.6288102

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EMCURE

43.08

35663.66

EPS(TTM)

Face Value()

Div & Yield %

43.64

0.19

Back

Coforge consolidated net profit rises 63.39% in the June 2026 quarter

Jul 28,2026

Net profit of Coforge rose 63.39% to Rs 518.60 crore in the quarter ended June 2026 as against Rs 317.40 crore during the previous quarter ended June 2025. Sales rose 49.22% to Rs 5527.70 crore in the quarter ended June 2026 as against Rs 3704.40 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5527.70	3704.40	49
OPM %	19.14	15.58	-
PBDT	998.20	549.40	82
PBT	757.10	390.20	94
NP	518.60	317.40	63

77,537.72 628.04 ( 0.82%)

52,797.06 -686.99 (-1.28%)

7,662.83 -66.15 (-0.86%)

66,220.29 893.87 (1.37%)

10,756.24 12.89 (0.12%)

95.70 0.10 (0.10%)

110.78 0.02 (0.01%)

129.52 -0.04 (-0.03%)

0.60 0.00 (-0.13%)